Medical Care

Global Drug Safety Solutions and Pharmacovigilance Market Research Report 2025

The global market for Drug Safety Solutions and Pharmacovigilance was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Drug safety evaluation, also known as non-clinical drug safety evaluation, refers to the evaluation of the safety of therapeutic drugs through laboratory research and animal in vitro systems. It is a necessary procedure and important step before new drugs enter final clinical trials and final approval. . Drug safety must first be drafted protocols and protocols. These studies, such as general acute chronic toxicity studies, pathohistological studies, reproductive toxicity tests, genotoxicity studies, safety pharmacology studies, investigation studies, and toxicity and safety biomarker studies. Due to the volume of the very successful methods in the Molecular Biology series, the chapters include a brief introduction to the respective disciplines, a list of required materials, a step-by-step, repeatable protocol, and tips on troubleshooting and avoiding known pitfalls.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Safety Solutions and Pharmacovigilance, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Safety Solutions and Pharmacovigilance.
The Drug Safety Solutions and Pharmacovigilance market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Safety Solutions and Pharmacovigilance market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Safety Solutions and Pharmacovigilance companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pharmaceutical Product Development, LLC
Drug Safety Solutions Limited
C3i
Worldwide Clinical Trials
Bioclinica
United Biosource LLC
Ennov
AB Cube
Covance Inc.
Accenture
PRA Health Sciences, Inc.
Ergomed
IQVIA
Genpact
Cognizant
Parexel International Corporation
ArisGlobal
ICON plc
Oracle
Syneos Health
Segment by Type
Standard Form
Customized Form
Segment by Application
Biotechnology and Pharmaceuticals
Contract Research Organization (CROS)
Hospital
KPO / BPO
Healthcare Institutions
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Safety Solutions and Pharmacovigilance company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Standard Form
1.2.3 Customized Form
1.3 Market by Application
1.3.1 Global Drug Safety Solutions and Pharmacovigilance Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology and Pharmaceuticals
1.3.3 Contract Research Organization (CROS)
1.3.4 Hospital
1.3.5 KPO / BPO
1.3.6 Healthcare Institutions
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Safety Solutions and Pharmacovigilance Market Perspective (2020-2031)
2.2 Global Drug Safety Solutions and Pharmacovigilance Growth Trends by Region
2.2.1 Global Drug Safety Solutions and Pharmacovigilance Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Safety Solutions and Pharmacovigilance Historic Market Size by Region (2020-2025)
2.2.3 Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Region (2026-2031)
2.3 Drug Safety Solutions and Pharmacovigilance Market Dynamics
2.3.1 Drug Safety Solutions and Pharmacovigilance Industry Trends
2.3.2 Drug Safety Solutions and Pharmacovigilance Market Drivers
2.3.3 Drug Safety Solutions and Pharmacovigilance Market Challenges
2.3.4 Drug Safety Solutions and Pharmacovigilance Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Safety Solutions and Pharmacovigilance Players by Revenue
3.1.1 Global Top Drug Safety Solutions and Pharmacovigilance Players by Revenue (2020-2025)
3.1.2 Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Players (2020-2025)
3.2 Global Drug Safety Solutions and Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Safety Solutions and Pharmacovigilance Revenue
3.4 Global Drug Safety Solutions and Pharmacovigilance Market Concentration Ratio
3.4.1 Global Drug Safety Solutions and Pharmacovigilance Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Safety Solutions and Pharmacovigilance Revenue in 2024
3.5 Global Key Players of Drug Safety Solutions and Pharmacovigilance Head office and Area Served
3.6 Global Key Players of Drug Safety Solutions and Pharmacovigilance, Product and Application
3.7 Global Key Players of Drug Safety Solutions and Pharmacovigilance, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Safety Solutions and Pharmacovigilance Breakdown Data by Type
4.1 Global Drug Safety Solutions and Pharmacovigilance Historic Market Size by Type (2020-2025)
4.2 Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Type (2026-2031)
5 Drug Safety Solutions and Pharmacovigilance Breakdown Data by Application
5.1 Global Drug Safety Solutions and Pharmacovigilance Historic Market Size by Application (2020-2025)
5.2 Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Safety Solutions and Pharmacovigilance Market Size (2020-2031)
6.2 North America Drug Safety Solutions and Pharmacovigilance Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2020-2025)
6.4 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Safety Solutions and Pharmacovigilance Market Size (2020-2031)
7.2 Europe Drug Safety Solutions and Pharmacovigilance Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2020-2025)
7.4 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size (2020-2031)
8.2 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Safety Solutions and Pharmacovigilance Market Size (2020-2031)
9.2 Latin America Drug Safety Solutions and Pharmacovigilance Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2020-2025)
9.4 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size (2020-2031)
10.2 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pharmaceutical Product Development, LLC
11.1.1 Pharmaceutical Product Development, LLC Company Details
11.1.2 Pharmaceutical Product Development, LLC Business Overview
11.1.3 Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Introduction
11.1.4 Pharmaceutical Product Development, LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.1.5 Pharmaceutical Product Development, LLC Recent Development
11.2 Drug Safety Solutions Limited
11.2.1 Drug Safety Solutions Limited Company Details
11.2.2 Drug Safety Solutions Limited Business Overview
11.2.3 Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Introduction
11.2.4 Drug Safety Solutions Limited Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.2.5 Drug Safety Solutions Limited Recent Development
11.3 C3i
11.3.1 C3i Company Details
11.3.2 C3i Business Overview
11.3.3 C3i Drug Safety Solutions and Pharmacovigilance Introduction
11.3.4 C3i Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.3.5 C3i Recent Development
11.4 Worldwide Clinical Trials
11.4.1 Worldwide Clinical Trials Company Details
11.4.2 Worldwide Clinical Trials Business Overview
11.4.3 Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Introduction
11.4.4 Worldwide Clinical Trials Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.4.5 Worldwide Clinical Trials Recent Development
11.5 Bioclinica
11.5.1 Bioclinica Company Details
11.5.2 Bioclinica Business Overview
11.5.3 Bioclinica Drug Safety Solutions and Pharmacovigilance Introduction
11.5.4 Bioclinica Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.5.5 Bioclinica Recent Development
11.6 United Biosource LLC
11.6.1 United Biosource LLC Company Details
11.6.2 United Biosource LLC Business Overview
11.6.3 United Biosource LLC Drug Safety Solutions and Pharmacovigilance Introduction
11.6.4 United Biosource LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.6.5 United Biosource LLC Recent Development
11.7 Ennov
11.7.1 Ennov Company Details
11.7.2 Ennov Business Overview
11.7.3 Ennov Drug Safety Solutions and Pharmacovigilance Introduction
11.7.4 Ennov Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.7.5 Ennov Recent Development
11.8 AB Cube
11.8.1 AB Cube Company Details
11.8.2 AB Cube Business Overview
11.8.3 AB Cube Drug Safety Solutions and Pharmacovigilance Introduction
11.8.4 AB Cube Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.8.5 AB Cube Recent Development
11.9 Covance Inc.
11.9.1 Covance Inc. Company Details
11.9.2 Covance Inc. Business Overview
11.9.3 Covance Inc. Drug Safety Solutions and Pharmacovigilance Introduction
11.9.4 Covance Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.9.5 Covance Inc. Recent Development
11.10 Accenture
11.10.1 Accenture Company Details
11.10.2 Accenture Business Overview
11.10.3 Accenture Drug Safety Solutions and Pharmacovigilance Introduction
11.10.4 Accenture Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.10.5 Accenture Recent Development
11.11 PRA Health Sciences, Inc.
11.11.1 PRA Health Sciences, Inc. Company Details
11.11.2 PRA Health Sciences, Inc. Business Overview
11.11.3 PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Introduction
11.11.4 PRA Health Sciences, Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.11.5 PRA Health Sciences, Inc. Recent Development
11.12 Ergomed
11.12.1 Ergomed Company Details
11.12.2 Ergomed Business Overview
11.12.3 Ergomed Drug Safety Solutions and Pharmacovigilance Introduction
11.12.4 Ergomed Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.12.5 Ergomed Recent Development
11.13 IQVIA
11.13.1 IQVIA Company Details
11.13.2 IQVIA Business Overview
11.13.3 IQVIA Drug Safety Solutions and Pharmacovigilance Introduction
11.13.4 IQVIA Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.13.5 IQVIA Recent Development
11.14 Genpact
11.14.1 Genpact Company Details
11.14.2 Genpact Business Overview
11.14.3 Genpact Drug Safety Solutions and Pharmacovigilance Introduction
11.14.4 Genpact Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.14.5 Genpact Recent Development
11.15 Cognizant
11.15.1 Cognizant Company Details
11.15.2 Cognizant Business Overview
11.15.3 Cognizant Drug Safety Solutions and Pharmacovigilance Introduction
11.15.4 Cognizant Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.15.5 Cognizant Recent Development
11.16 Parexel International Corporation
11.16.1 Parexel International Corporation Company Details
11.16.2 Parexel International Corporation Business Overview
11.16.3 Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Introduction
11.16.4 Parexel International Corporation Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.16.5 Parexel International Corporation Recent Development
11.17 ArisGlobal
11.17.1 ArisGlobal Company Details
11.17.2 ArisGlobal Business Overview
11.17.3 ArisGlobal Drug Safety Solutions and Pharmacovigilance Introduction
11.17.4 ArisGlobal Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.17.5 ArisGlobal Recent Development
11.18 ICON plc
11.18.1 ICON plc Company Details
11.18.2 ICON plc Business Overview
11.18.3 ICON plc Drug Safety Solutions and Pharmacovigilance Introduction
11.18.4 ICON plc Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.18.5 ICON plc Recent Development
11.19 Oracle
11.19.1 Oracle Company Details
11.19.2 Oracle Business Overview
11.19.3 Oracle Drug Safety Solutions and Pharmacovigilance Introduction
11.19.4 Oracle Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.19.5 Oracle Recent Development
11.20 Syneos Health
11.20.1 Syneos Health Company Details
11.20.2 Syneos Health Business Overview
11.20.3 Syneos Health Drug Safety Solutions and Pharmacovigilance Introduction
11.20.4 Syneos Health Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
11.20.5 Syneos Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Standard Form
Table 3. Key Players of Customized Form
Table 4. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Drug Safety Solutions and Pharmacovigilance Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Drug Safety Solutions and Pharmacovigilance Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Drug Safety Solutions and Pharmacovigilance Market Share by Region (2020-2025)
Table 8. Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Drug Safety Solutions and Pharmacovigilance Market Share by Region (2026-2031)
Table 10. Drug Safety Solutions and Pharmacovigilance Market Trends
Table 11. Drug Safety Solutions and Pharmacovigilance Market Drivers
Table 12. Drug Safety Solutions and Pharmacovigilance Market Challenges
Table 13. Drug Safety Solutions and Pharmacovigilance Market Restraints
Table 14. Global Drug Safety Solutions and Pharmacovigilance Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Drug Safety Solutions and Pharmacovigilance Market Share by Players (2020-2025)
Table 16. Global Top Drug Safety Solutions and Pharmacovigilance Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety Solutions and Pharmacovigilance as of 2024)
Table 17. Ranking of Global Top Drug Safety Solutions and Pharmacovigilance Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Drug Safety Solutions and Pharmacovigilance Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Drug Safety Solutions and Pharmacovigilance, Headquarters and Area Served
Table 20. Global Key Players of Drug Safety Solutions and Pharmacovigilance, Product and Application
Table 21. Global Key Players of Drug Safety Solutions and Pharmacovigilance, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Safety Solutions and Pharmacovigilance Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Type (2020-2025)
Table 25. Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Type (2026-2031)
Table 27. Global Drug Safety Solutions and Pharmacovigilance Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Application (2020-2025)
Table 29. Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Application (2026-2031)
Table 31. North America Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pharmaceutical Product Development, LLC Company Details
Table 47. Pharmaceutical Product Development, LLC Business Overview
Table 48. Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Product
Table 49. Pharmaceutical Product Development, LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 50. Pharmaceutical Product Development, LLC Recent Development
Table 51. Drug Safety Solutions Limited Company Details
Table 52. Drug Safety Solutions Limited Business Overview
Table 53. Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Product
Table 54. Drug Safety Solutions Limited Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 55. Drug Safety Solutions Limited Recent Development
Table 56. C3i Company Details
Table 57. C3i Business Overview
Table 58. C3i Drug Safety Solutions and Pharmacovigilance Product
Table 59. C3i Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 60. C3i Recent Development
Table 61. Worldwide Clinical Trials Company Details
Table 62. Worldwide Clinical Trials Business Overview
Table 63. Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Product
Table 64. Worldwide Clinical Trials Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 65. Worldwide Clinical Trials Recent Development
Table 66. Bioclinica Company Details
Table 67. Bioclinica Business Overview
Table 68. Bioclinica Drug Safety Solutions and Pharmacovigilance Product
Table 69. Bioclinica Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 70. Bioclinica Recent Development
Table 71. United Biosource LLC Company Details
Table 72. United Biosource LLC Business Overview
Table 73. United Biosource LLC Drug Safety Solutions and Pharmacovigilance Product
Table 74. United Biosource LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 75. United Biosource LLC Recent Development
Table 76. Ennov Company Details
Table 77. Ennov Business Overview
Table 78. Ennov Drug Safety Solutions and Pharmacovigilance Product
Table 79. Ennov Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 80. Ennov Recent Development
Table 81. AB Cube Company Details
Table 82. AB Cube Business Overview
Table 83. AB Cube Drug Safety Solutions and Pharmacovigilance Product
Table 84. AB Cube Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 85. AB Cube Recent Development
Table 86. Covance Inc. Company Details
Table 87. Covance Inc. Business Overview
Table 88. Covance Inc. Drug Safety Solutions and Pharmacovigilance Product
Table 89. Covance Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 90. Covance Inc. Recent Development
Table 91. Accenture Company Details
Table 92. Accenture Business Overview
Table 93. Accenture Drug Safety Solutions and Pharmacovigilance Product
Table 94. Accenture Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 95. Accenture Recent Development
Table 96. PRA Health Sciences, Inc. Company Details
Table 97. PRA Health Sciences, Inc. Business Overview
Table 98. PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Product
Table 99. PRA Health Sciences, Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 100. PRA Health Sciences, Inc. Recent Development
Table 101. Ergomed Company Details
Table 102. Ergomed Business Overview
Table 103. Ergomed Drug Safety Solutions and Pharmacovigilance Product
Table 104. Ergomed Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 105. Ergomed Recent Development
Table 106. IQVIA Company Details
Table 107. IQVIA Business Overview
Table 108. IQVIA Drug Safety Solutions and Pharmacovigilance Product
Table 109. IQVIA Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 110. IQVIA Recent Development
Table 111. Genpact Company Details
Table 112. Genpact Business Overview
Table 113. Genpact Drug Safety Solutions and Pharmacovigilance Product
Table 114. Genpact Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 115. Genpact Recent Development
Table 116. Cognizant Company Details
Table 117. Cognizant Business Overview
Table 118. Cognizant Drug Safety Solutions and Pharmacovigilance Product
Table 119. Cognizant Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 120. Cognizant Recent Development
Table 121. Parexel International Corporation Company Details
Table 122. Parexel International Corporation Business Overview
Table 123. Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Product
Table 124. Parexel International Corporation Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 125. Parexel International Corporation Recent Development
Table 126. ArisGlobal Company Details
Table 127. ArisGlobal Business Overview
Table 128. ArisGlobal Drug Safety Solutions and Pharmacovigilance Product
Table 129. ArisGlobal Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 130. ArisGlobal Recent Development
Table 131. ICON plc Company Details
Table 132. ICON plc Business Overview
Table 133. ICON plc Drug Safety Solutions and Pharmacovigilance Product
Table 134. ICON plc Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 135. ICON plc Recent Development
Table 136. Oracle Company Details
Table 137. Oracle Business Overview
Table 138. Oracle Drug Safety Solutions and Pharmacovigilance Product
Table 139. Oracle Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 140. Oracle Recent Development
Table 141. Syneos Health Company Details
Table 142. Syneos Health Business Overview
Table 143. Syneos Health Drug Safety Solutions and Pharmacovigilance Product
Table 144. Syneos Health Revenue in Drug Safety Solutions and Pharmacovigilance Business (2020-2025) & (US$ Million)
Table 145. Syneos Health Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 149. Authors List of This Report


List of Figures
Figure 1. Drug Safety Solutions and Pharmacovigilance Picture
Figure 2. Global Drug Safety Solutions and Pharmacovigilance Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug Safety Solutions and Pharmacovigilance Market Share by Type: 2024 VS 2031
Figure 4. Standard Form Features
Figure 5. Customized Form Features
Figure 6. Global Drug Safety Solutions and Pharmacovigilance Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Drug Safety Solutions and Pharmacovigilance Market Share by Application: 2024 VS 2031
Figure 8. Biotechnology and Pharmaceuticals Case Studies
Figure 9. Contract Research Organization (CROS) Case Studies
Figure 10. Hospital Case Studies
Figure 11. KPO / BPO Case Studies
Figure 12. Healthcare Institutions Case Studies
Figure 13. Others Case Studies
Figure 14. Drug Safety Solutions and Pharmacovigilance Report Years Considered
Figure 15. Global Drug Safety Solutions and Pharmacovigilance Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Drug Safety Solutions and Pharmacovigilance Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Drug Safety Solutions and Pharmacovigilance Market Share by Region: 2024 VS 2031
Figure 18. Global Drug Safety Solutions and Pharmacovigilance Market Share by Players in 2024
Figure 19. Global Top Drug Safety Solutions and Pharmacovigilance Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety Solutions and Pharmacovigilance as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Drug Safety Solutions and Pharmacovigilance Revenue in 2024
Figure 21. North America Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Drug Safety Solutions and Pharmacovigilance Market Share by Country (2020-2031)
Figure 23. United States Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Drug Safety Solutions and Pharmacovigilance Market Share by Country (2020-2031)
Figure 27. Germany Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Share by Region (2020-2031)
Figure 35. China Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Drug Safety Solutions and Pharmacovigilance Market Share by Country (2020-2031)
Figure 43. Mexico Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Share by Country (2020-2031)
Figure 47. Turkey Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Pharmaceutical Product Development, LLC Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 51. Drug Safety Solutions Limited Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 52. C3i Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 53. Worldwide Clinical Trials Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 54. Bioclinica Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 55. United Biosource LLC Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 56. Ennov Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 57. AB Cube Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 58. Covance Inc. Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 59. Accenture Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 60. PRA Health Sciences, Inc. Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 61. Ergomed Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 62. IQVIA Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 63. Genpact Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 64. Cognizant Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 65. Parexel International Corporation Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 66. ArisGlobal Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 67. ICON plc Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 68. Oracle Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 69. Syneos Health Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies